Shilpa Medicare Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023-24🗂️ Report periods on file: 2023-24, 2022-23

In its 2023-24 reporting, Shilpa Medicare Limited disclosed greenhouse gas emissions of 3.7K tCO2e/year (Scope 1) and 20389.90 tCO2e/year (Scope 2). By scope: Scope 1: 3.7K tCO2e/year; Scope 2: 20.4K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
3.7K tCO2e/year (Scope 1) and 20389.90 tCO2e/year (Scope 2)
2023-24
⚡
Renewable Energy
88.3%
of total energy
💧
Water Usage
51.6K m3/year
2023-24
♻️
Waste
90.59 tons/year
2023-24

📊 Emissions by Scope (2023-24)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).3.7K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.20.4K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2023-243.7K tCO2e/year (Scope 1) and 20389.90 tCO2e/year (Scope 2)
2022-2327.3K tCO2e/year (Scope 1 & 2)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

📅 Medium-term

  • 100% powered by renewable sources by 2030

🔭 Long-term

  • Net zero carbon Company by 2050

🌱 ESG Focus Areas

EnvironmentalSocialGovernance

⚠️ Challenges & Risks +

  • Regulatory requirement alterations can lead to compliance challenges, affecting product approvals.
  • Pricing and market share may feel pressured due to competitive scenario.
  • Challenges related to patent litigation or IP rights, can lead to significant legal costs and market exclusivity loss.
  • Supply Chain disruptions for raw materials can lead to production delays and increased costs.
  • Potential health risks posed by products can lead to liability claims and reputational damage.
  • Operations can be disrupted and profitability can be hampered due to instability in key markets.
  • Obsoletion of existing products or packages may be caused by rapid technological changes.

📋 Report Information

Reporting Period: 2023-24
Frameworks: UNGC, SBTi